Trials / Sponsors / MeiraGTx, LLC
MeiraGTx, LLC
Industry · 6 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Enrolling By Invitation | Long-term Follow-up of Gene Therapy for Radiation-Induced Xerostomia Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands | Phase 2 | 2024-08-02 |
| Recruiting | A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands | Phase 2 | 2023-06-13 |
| Active Not Recruiting | Long-term Follow-up of Glutamic Acid Decarboxylase (GAD) Gene Transfer in Parkinson's Disease Parkinson's Disease | Phase 1 / Phase 2 | 2023-05-19 |
| Completed | A Double-blind Study to Evaluate the Safety of Glutamic Acid Decarboxylase Gene Transfer in Parkinson's Partic Parkinson's Disease | Phase 1 / Phase 2 | 2022-10-05 |
| Active Not Recruiting | Long-Term Follow-Up Study of AAV2hAQP1 for Radiation Induced Xerostomia Radiation-induced Xerostomia | — | 2020-11-12 |
| Active Not Recruiting | Safety of a Single Administration of AAV2hAQP1, an Adeno-Associated Viral Vector Encoding Human Aquaporin-1 to Squamous Cell Head and Neck Cancer, Radiation Induced Xerostomia, Salivary Hypofunction | Phase 1 | 2015-05-04 |